Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gaedigk

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of Clinical Pharmacology|January 26, 2002
Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformationS M Abdel-Rahman, J S Leeder, J T Wilson, et al.
Clinical Pharmacology and Therapeutics|November 4, 2000
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail"D S Streetman, J F Bleakley, J S Kim, et al.
The Pharmacogenomics Journal|March 16, 2005
Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African AmericansA Gaedigk, A Bhathena, L Ndjountché, et al.
Clinical Pharmacology and Therapeutics|June 16, 2016
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS ProteomicsB Prasad, A Gaedigk, M Vrana, et al.
Clinical Pharmacology and Therapeutics|February 16, 2007
Ontogeny of dextromethorphan O- and N-demethylation in the first year of lifeM J Blake, A Gaedigk, R E Pearce, et al.
Clinical Pharmacology and Therapeutics|March 15, 2013
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressantsJ K Hicks, J J Swen, C F Thorn, et al.
Clinical Pharmacology and Therapeutics|January 30, 2007
Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication eventsA Gaedigk, L Ndjountché, K Divakaran, et al.
Clinical Pharmacology and Therapeutics|January 25, 2014
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 updateK R Crews, A Gaedigk, H M Dunnenberger, et al.
Clinical Pharmacology and Therapeutics|May 15, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake InhibitorsJ K Hicks, J R Bishop, K Sangkuhl, et al.
Clinical Pharmacology and Therapeutics|October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reportingL V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of Clinical Pharmacology|January 26, 2002
Concordance between tramadol and dextromethorphan parent/metabolite ratios: the influence of CYP2D6 and non-CYP2D6 pathways on biotransformationS M Abdel-Rahman, J S Leeder, J T Wilson, et al.
Clinical Pharmacology and Therapeutics|November 4, 2000
Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail"D S Streetman, J F Bleakley, J S Kim, et al.
The Pharmacogenomics Journal|March 16, 2005
Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African AmericansA Gaedigk, A Bhathena, L Ndjountché, et al.
Clinical Pharmacology and Therapeutics|June 16, 2016
Ontogeny of Hepatic Drug Transporters as Quantified by LC-MS/MS ProteomicsB Prasad, A Gaedigk, M Vrana, et al.
Clinical Pharmacology and Therapeutics|February 16, 2007
Ontogeny of dextromethorphan O- and N-demethylation in the first year of lifeM J Blake, A Gaedigk, R E Pearce, et al.
Clinical Pharmacology and Therapeutics|March 15, 2013
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressantsJ K Hicks, J J Swen, C F Thorn, et al.
Clinical Pharmacology and Therapeutics|January 30, 2007
Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication eventsA Gaedigk, L Ndjountché, K Divakaran, et al.
Clinical Pharmacology and Therapeutics|January 25, 2014
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 updateK R Crews, A Gaedigk, H M Dunnenberger, et al.
Clinical Pharmacology and Therapeutics|May 15, 2015
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake InhibitorsJ K Hicks, J R Bishop, K Sangkuhl, et al.
Clinical Pharmacology and Therapeutics|October 20, 2015
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reportingL V Kalman, Jag Agúndez, M Lindqvist Appell, et al.
Pageof 5